Awardee OrganizationUNIVERSITY OF CALIFORNIA AT DAVIS
Description
Abstract Text
PROJECT SUMMARY
Suicide is a leading cause of death in the United States (US). Firearms are the most commonly used
and most lethal method of suicide. While firearm access has been consistently and strongly associated with
increased risk of firearm suicide, firearm suicides cannot be explained by firearm access alone. Indeed, the
vast majority of the estimated 54.7 million firearm owners in the US do not die by firearm suicide. To advance
firearm suicide prevention interventions—which are often risk-based rather than universal—we must accurately
identify additional and contributing risk factors for firearm suicide.
One such factor may be opioid-related harm (e.g., opioid use disorder [OUD], overdose), which has
increased exponentially in the US since 1999. OUD has been associated with suicide in the general
population. Research on risky opioid use among firearm owners is limited, though substance use is more
common among firearm owners than non-firearm-owners and evidence suggests the link between substance
use and suicide extends to firearm owners. Further, the impact of the opioid crisis likely extends beyond the
direct effects on individuals who use opioids, yet few prior studies have considered opioid-related harm as a
contextual factor that may contribute to variations in firearm suicide risk across communities and populations.
This study seeks to examine the synergistic impacts of firearm access and opioid-related harm on
firearm suicide risk at both the individual and population levels. Our goals are to determine whether personal
firearm ownership moderates the impact of individual and community opioid-related harm on individual firearm
suicide risk and similarly, whether firearm availability moderates the impact of community opioid-related harm
on firearm suicide rates. At the individual level, we will use a case-control design, drawing from over 2.6 million
deaths in California from 2008 to 2018, with firearm access defined by known individual legal firearm
acquisitions and opioid-related harm defined by prior opioid-related emergency or hospital visits. At the
population level, we will use a fixed effects and time series analysis of firearm suicide rates in California from
2005 to 2018. Firearm availability will be defined by a novel and improved measure—the number of legal
firearm purchasers per county population across the entire study period—and opioid-related harm will be
defined by the lagged rate of nonfatal opioid-related visits and fatal unintentional overdoses.
Studying joint impacts will help identify the most at-risk populations with the greatest burden of firearm
suicide and further explicate the etiology of firearm suicide. It also offers multiple levers for risk-based
intervention; we may need only intervene on one component to prevent the outcome. Results of our project are
therefore likely to inform innovative and promising opportunities to enhance safety and prevent self-directed
firearm-related injuries and deaths. We are seeking funding under Objective One, Funding Option A.
Public Health Relevance Statement
PROJECT NARRATIVE
Firearm access is consistently and strongly associated with increased risk of firearm suicide, a
leading cause of death in the United States, but firearm suicides cannot be explained by firearm
access alone. One additional factor may be opioid-related harm (e.g., opioid use disorder,
overdose), which has increased exponentially since 1999. This study seeks to examine the
synergistic impacts of firearm access and opioid-related harm on firearm suicide risk at both the
population and individual levels.
No Sub Projects information available for 1R01CE003259-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01CE003259-01
Patents
No Patents information available for 1R01CE003259-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01CE003259-01
Clinical Studies
No Clinical Studies information available for 1R01CE003259-01
News and More
Related News Releases
No news release information available for 1R01CE003259-01
History
No Historical information available for 1R01CE003259-01
Similar Projects
No Similar Projects information available for 1R01CE003259-01